The store will not work correctly when cookies are disabled.
3-[3-(8-quinolinyloxy)propoxy]-2,6-difluorobenzamide
ID: ALA4097421
PubChem CID: 137661086
Max Phase: Preclinical
Molecular Formula: C19H16F2N2O3
Molecular Weight: 358.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCCOc2cccc3cccnc23)c1F
Standard InChI: InChI=1S/C19H16F2N2O3/c20-13-7-8-14(17(21)16(13)19(22)24)25-10-3-11-26-15-6-1-4-12-5-2-9-23-18(12)15/h1-2,4-9H,3,10-11H2,(H2,22,24)
Standard InChI Key: FEGAGSOIVQTQGV-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
16.4070 -22.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4059 -23.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1207 -23.6528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8372 -23.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1189 -21.9999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8306 -22.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5402 -21.9999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5393 -21.1784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8228 -20.7693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1162 -21.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5531 -23.6493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2661 -23.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9821 -23.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6950 -23.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4110 -23.6384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1240 -23.2233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8382 -23.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5506 -23.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5480 -22.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8269 -21.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1174 -22.4007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3997 -21.9937 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.2603 -21.9773 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.8209 -21.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5323 -20.7411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1034 -20.7516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
21 22 1 0
19 23 1 0
20 24 1 0
24 25 1 0
24 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.34 | Molecular Weight (Monoisotopic): 358.1129 | AlogP: 3.46 | #Rotatable Bonds: 7 |
Polar Surface Area: 74.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: 2.87 | CX LogP: 2.81 | CX LogD: 2.81 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.66 | Np Likeness Score: -1.16 |
References
1. Hu Z, Zhang S, Zhou W, Ma X, Xiang G.. (2017) Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors., 27 (8): [PMID:28285910] [10.1016/j.bmcl.2017.02.032] |